MODERN APPROACHES TO THE TREATMENT OF PULMONARY FIBROSIS IN SYSTEMIC SCLEROSIS

Systemic sclerosis is a chronic autoimmune disease affecting multiple organs, including the lungs. Pulmonary fibrosis in systemic sclerosis significantly reduces lung function, leading to respiratory insufficiency and deterioration in quality of life. This article analyzes current approaches to managing pulmonary fibrosis in systemic sclerosis. The effectiveness of traditional immunosuppressive therapy, antifibrotic drugs, biological therapy, and targeted molecular treatments is reviewed. Individualized treatment strategies and results from recent clinical trials are also discussed. These modern approaches aim to stabilize lung function, slow disease progression, and improve patient quality of life.